Literature DB >> 1826067

Elevation of plasma endothelin associated with systemic hypertension in humans following orthotopic liver transplantation.

A Lerman1, R L Click, B J Narr, R H Wiesner, R A Krom, S C Textor, J C Burnett.   

Abstract

Endothelin (ET) is a 21-amino-acid peptide of endothelial origin, is a potent systemic and renal vasoconstrictor associated with sodium retention and modulation of the renin-angiotensin-aldosterone system. The present study was designed to determine if plasma ET is elevated in humans with cirrhosis (n = 12), a state characterized by sodium retention and increased plasma renin activity (PRA) and plasma aldosterone (PA), and to determine the effect of orthotopic liver transplantation (OLT) upon plasma ET, PRA, and PA at 1, 3, and 7 days after transplantation. Plasma ET before OLT was 1.62 +/- 0.23 pg/ml, which was not different as compared with normal controls. Plasma ET significantly increased to 4.18 +/- 0.66, 3.87 +/- 0.58, and 4.07 +/- 0.61 pg/ml, respectively following OLT. PRA remained elevated throughout the postoperative course, in contrast to PA that decreased following OLT. Mean arterial pressure increased significantly from 82 +/- 4 pre-OLT to 98 +/- 4 and 103 +/- 2 mmHG on days 3 and 7 respectively.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1826067     DOI: 10.1097/00007890-199103000-00020

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  13 in total

1.  Effects of orthotopic liver transplantation on vasoactive systems and renal function in patients with advanced liver cirrhosis.

Authors:  Concepcíon Cassinello; Enrique Moreno; Adolfo Gozalo; Blanca Ortuño; Beatriz Cuenca; José Antonio Solís-Herruzo
Journal:  Dig Dis Sci       Date:  2003-01       Impact factor: 3.199

2.  The production and clearance of endothelin and its influence on kidney function after liver transplantation in rats.

Authors:  M Shiraishi; T Kusano; S Hiroyasu; J Hara; T Aihara; Y Muto
Journal:  Surg Today       Date:  1997       Impact factor: 2.549

3.  Magnesium-deficiency elevates circulating levels of inflammatory cytokines and endothelin.

Authors:  W B Weglicki; T M Phillips; A M Freedman; M M Cassidy; B F Dickens
Journal:  Mol Cell Biochem       Date:  1992-03-25       Impact factor: 3.396

4.  Endothelin-1 levels in portal venous blood in relation to hepatic tissue microcirculation disturbance and hepatic cell injury after ischemia/reperfusion.

Authors:  T Ota; R Hirai; A Urakami; H Soga; S Nawa; N Shimizu
Journal:  Surg Today       Date:  1997       Impact factor: 2.549

5.  Hepatic effects of endothelin. Receptor characterization and endothelin-induced signal transduction in hepatocytes.

Authors:  C R Gandhi; R H Behal; S A Harvey; T A Nouchi; M S Olson
Journal:  Biochem J       Date:  1992-11-01       Impact factor: 3.857

6.  Gene expression, localization, and characterization of endothelin A and B receptors in the human adrenal cortex.

Authors:  G Rossi; G Albertin; A Belloni; L Zanin; M A Biasolo; T Prayer-Galetti; M Bader; G G Nussdorfer; G Palù; A C Pessina
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

7.  Clinical significance of plasma endothelin-1 in patients with chronic liver disease.

Authors:  H Matsumoto; J Uemasu; M Kitano; H Kawasaki
Journal:  Dig Dis Sci       Date:  1994-12       Impact factor: 3.199

8.  Plasma endothelin-1 concentrations are elevated in acute hepatitis and liver cirrhosis but not in chronic hepatitis.

Authors:  Y Uchida; M Watanabe
Journal:  Gastroenterol Jpn       Date:  1993-10

9.  Endothelin-1 immunoreactivity in plasma is elevated in HIV-1 infected patients with retinal microangiopathic syndrome.

Authors:  B Rolinski; S A Geier; I Sadri; V Klauss; J R Bogner; H Ehrenreich; F D Goebel
Journal:  Clin Investig       Date:  1994-03

Review 10.  The influence of long-term morbidity on health status and rehabilitation following paediatric organ transplantation.

Authors:  P A Keown; C R Shackleton; B M Ferguson
Journal:  Eur J Pediatr       Date:  1992       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.